Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ
Closed
Oct 6, 2026
Day's Range
60.5652 wk Range
34.61Overview - ARWR - Arrowhead Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
8.84B
P/E (Trailing)
‪47.10‬
P/E (Forward)
‪-13.01‬
PEG Ratio
‪5.93‬
Price / Sales (TTM)
‪13.50‬
Price / Book
‪19.46‬
EV / EBITDA
‪-44.10‬
Profitability
Profit Margin
‪-47.79%‬
Operating Margin
‪-226.02%‬
Return on Assets
‪-8.10%‬
Return on Equity
‪-55.20%‬
Ownership
Shares Outstanding
141.13M
Float
122.44M
Short % of Shares Outstanding
‪9.13%‬
Held by Insiders
‪3.65%‬
Held by Institutions
‪85.43%‬
Price stats
Beta
‪1.28‬
50-Day Avg
‪80.81‬
200-Day Avg
‪72.49‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
14 analysts
Average price target
‪$ 110.18‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ARWR - Arrowhead Pharmaceuticals, Inc.
Peers - ARWR - Arrowhead Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ARWRNASDAQArrowhead Pharmaceuticals, Inc.9.06BMarket Cap+41.58%52-week change47.10P/E (Trailing)‪-47.79%‬Profit Margin
- ARGXNASDAQArgenx SE57.50BMarket Cap+14.28%52-week change34.96P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.40BMarket Cap-105.72%52-week change38.35P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share24.34BMarket Cap-8.52%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.99BMarket Cap+7.48%52-week change17.72P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.14BMarket Cap+18.80%52-week change-17.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.11.06BMarket Cap+2.75%52-week change154.54P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - ARWR - Arrowhead Pharmaceuticals, Inc.
About
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company that develops medicines for intractable diseases using RNA interference, a gene-silencing approach designed to reduce the production of disease-causing proteins. Arrowhead Pharmaceuticals focuses on therapeutic areas including cardiometabolic, liver,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
